Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine-Reference-Cited by-同舟云学术

Use of Therapeutic Drug Monitoring, Electronic Health Record Data, and Pharmacokinetic Modeling to Determine the Therapeutic Index of Phenytoin and Lamotrigine

Published:2016-12 Issue:6 Volume:38 Page:728-737
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Ku Lawrence C.,Wu Huali,Greenberg Rachel G.,Hill Kevin D.,Gonzalez Daniel,Hornik Christoph P.,Berezny Alysha,Guptill Jeffrey T.,Jiang Wenlei,Zheng Nan,Cohen-Wolkowiez Michael,Melloni Chiara

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference51 articles.

1. What are narrow therapeutic index drugs?;Levy;Clin Pharmacol Ther.,1998

2. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide;Tamargo;Eur J Clin Pharmacol.,2015

3. Novel bioequivalence approach for narrow therapeutic index drugs;Yu;Clin Pharmacol Ther.,2015

4. Deficiencies of the FDA in evaluating generic formulations: addressing narrow therapeutic index drugs;Hottinger;Am J Law Med.,2012

5. The controversy over generic antiepileptic drugs;Shaw;J Pediatr Pharmacol Ther.,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between simulated ketamine exposures and oxygen saturations in children;International Journal of Pharmacokinetics;2022-03

2. Redefining the age-specific therapeutic ranges of lamotrigine for patients with epilepsy: A step towards optimizing treatment and increasing cost-effectiveness;Epilepsy Research;2021-10

3. The relationship between simulated milrinone exposure and hypotension in children;Cardiology in the Young;2021-08-05

4. Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling;Drugs in R&D;2020-10-07

5. Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables;Frontiers in Pharmacology;2020-04-22